These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Primary non-Hodgkin's lymphoma of bone: a rare disorder with high frequency of T-cell phenotype in southern Taiwan. Hsieh PP; Tseng HH; Chang ST; Fu TY; Lu CL; Chuang SS Leuk Lymphoma; 2006 Jan; 47(1):65-70. PubMed ID: 16321829 [TBL] [Abstract][Full Text] [Related]
25. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576 [TBL] [Abstract][Full Text] [Related]
26. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. López-Guillermo A; Montserrat E; Bosch F; Terol MJ; Campo E; Rozman C J Clin Oncol; 1994 Jul; 12(7):1343-8. PubMed ID: 8021724 [TBL] [Abstract][Full Text] [Related]
27. Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study. Fleury I; Amorim S; Mounier N; Coiffier B; Dupuis J; Tilly H; Mazari MA; Filliatre L; Brière J; Brice P; de Kerviler E; Thieblemont C Leuk Lymphoma; 2015 Jul; 56(7):2025-31. PubMed ID: 25347431 [TBL] [Abstract][Full Text] [Related]
28. Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases. Su YJ; Wang PN; Chang H; Shih LY; Lin TL; Kuo MC; Chuang WY; Wu JH; Tang TC; Hung YS; Dunn P; Kao HW Eur J Haematol; 2018 Sep; 101(3):379-388. PubMed ID: 29908084 [TBL] [Abstract][Full Text] [Related]
29. A highly curable lymphoma occurs preferentially in the proximal tibia of young patients. Subik MK; Herr M; Hutchison RE; Kelly J; Tyler W; Merzianu M; Burack WR Mod Pathol; 2014 Nov; 27(11):1430-1437. PubMed ID: 24743213 [TBL] [Abstract][Full Text] [Related]
30. The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients. Painter D; Smith A; de Tute R; Crouch S; Roman E; Jack A Br J Haematol; 2015 Jul; 170(2):175-8. PubMed ID: 25920510 [TBL] [Abstract][Full Text] [Related]
31. Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. Conconi A; Raderer M; Franceschetti S; Devizzi L; Ferreri AJ; Magagnoli M; Arcaini L; Zinzani PL; Martinelli G; Vitolo U; Kiesewetter B; Porro E; Stathis A; Gaidano G; Cavalli F; Zucca E Br J Haematol; 2014 Jul; 166(1):69-76. PubMed ID: 24673512 [TBL] [Abstract][Full Text] [Related]
32. A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma. Luminari S; Goldaniga M; Cesaretti M; Orsucci L; Tucci A; Pulsoni A; Salvi F; Arcaini L; Carella AM; Tedeschi A; Pinto A; Stelitano C; Baldini L Leuk Lymphoma; 2016; 57(4):880-7. PubMed ID: 26379040 [TBL] [Abstract][Full Text] [Related]
33. Lymphoma of the Eyelid - An International Multicenter Retrospective Study. Svendsen FH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S Am J Ophthalmol; 2017 May; 177():58-68. PubMed ID: 28209503 [TBL] [Abstract][Full Text] [Related]
34. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. Ferreri AJ; Blay JY; Reni M; Pasini F; Spina M; Ambrosetti A; Calderoni A; Rossi A; Vavassori V; Conconi A; Devizzi L; Berger F; Ponzoni M; Borisch B; Tinguely M; Cerati M; Milani M; Orvieto E; Sanchez J; Chevreau C; Dell'Oro S; Zucca E; Cavalli F J Clin Oncol; 2003 Jan; 21(2):266-72. PubMed ID: 12525518 [TBL] [Abstract][Full Text] [Related]
35. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission. Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255 [TBL] [Abstract][Full Text] [Related]
36. Primary lymphoma of bone--survival and prognosis. Choi JY; Hahn JS; Suh CO; Yang WI Korean J Intern Med; 2002 Sep; 17(3):191-7. PubMed ID: 12298430 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experience. Wu H; Zhang L; Shao H; Sokol L; Sotomayor E; Letson D; Bui MM Br J Haematol; 2014 Jul; 166(1):60-8. PubMed ID: 24673481 [TBL] [Abstract][Full Text] [Related]
38. Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policy. Morabito F; Baldini L; Stelitano C; Luminari S; Frassoldati A; Merli F; Colombi M; Sabbatini R; Brugiatelli M; Federico M; Leuk Lymphoma; 2002 Oct; 43(10):1933-8. PubMed ID: 12481887 [TBL] [Abstract][Full Text] [Related]
39. The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases. Rigacci L; Federico M; Martelli M; Zinzani PL; Cavanna L; Bellesi G; Merli F; Alterini R; Petrucci MT; Tani M; Liberati AM; Vitolo U; Pavone V; Cuneo A; Chisesib T; Brugiatelli M; Leuk Lymphoma; 2003 Nov; 44(11):1911-7. PubMed ID: 14738142 [TBL] [Abstract][Full Text] [Related]
40. Primary malignant lymphoma of bone. Dargan SK Saudi Med J; 2000 Jan; 21(1):105. PubMed ID: 11533764 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]